ICD-10-CM Billable Code

Z12.13

Encounter for screening for malignant neoplasm of small intestine

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code Z12.13 refers to medical visits focused on screening for malignant neoplasm of the small intestine. This screening helps in early detection of potential cancerous growths, which can be crucial for effective treatment and improved survival rates. Patients undergoing this screening typically do so as part of routine health assessments or if they have risk factors that warrant closer examination of the small intestine. Early identification of abnormalities can lead to prompt intervention, potentially preventing the progression of cancer.

Causes & Symptoms

Clinical Causes: Genetic predisposition or family history of small intestine cancer Chronic inflammation of the small intestine, such as Crohn's disease History of radiation exposure in the abdominal area Certain hereditary syndromes associated with increased cancer risk Lifestyle factors like smoking, heavy alcohol use, and poor diet

Key Symptoms: Unexplained weight loss Persistent abdominal pain or discomfort Nausea or vomiting Digestive disturbances such as diarrhea or constipation Gastrointestinal bleeding leading to anemia Early-stage small intestine cancers often cause no noticeable symptoms

Diagnostic & Treatment

Diagnosis Path: The diagnosis process for screening the small intestine for malignant neoplasms typically involves multiple steps: - Medical history review and physical examination - Imaging studies like computed tomography (CT) scans or magnetic resonance imaging (MRI) - Endoscopic procedures, such as capsule endoscopy or enteroscopy, to visualize the small intestine - Biopsy samples taken during endoscopy to identify abnormal or cancerous cells - Laboratory tests to check for signs of anemia or other related issues Screening aims to detect abnormal growths early, often before symptoms develop, thus allowing for more effective intervention.

Treatment Protocols: Treatment options for small intestine malignancies depend on the size, location, and stage of the tumor: - Surgical removal of the affected segment of the small intestine - Chemotherapy to target cancer cells and prevent spread - Radiation therapy in select cases, particularly if the tumor is localized - Targeted biological therapies for specific cancer types - Supportive care to manage symptoms and improve quality of life It is essential that treatment plans are tailored to individual patient needs and determined by a multidisciplinary healthcare team.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z12.13 a billable ICD-10 code?
Yes, Z12.13 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z12.13?
Clinical documentation must specify the nature of Encounter for screening for malignant neoplasm of small intestine and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

intestine neoplasm screening malignant small encounter